• BASIC DRUG
    DISCUSSION
    Welcome to Bluelight!
    Posting Rules Bluelight Rules
    Benzo Chart Opioids Chart
    Drug Terms Need Help??
    Drugs 101 Brain & Addiction
    Tired of your habit? Struggling to cope?
    Want to regain control or get sober?
    Visit our Recovery Support Forums
  • BDD Moderators: Keif’ Richards | negrogesic

is methiopropamine a releaser or re-uptake inhibitor?

T9358

Bluelighter
Joined
Dec 5, 2012
Messages
92
After some research I have found some conflicting data basically indicating that thiopropamine ( unmethylated) is a releaser were as MPA is a re-uptake inhibitor with a preference for NE over DA. It does not make sense to me as methylation of a compound in my knowledge should not alter its pharmacological action that much.

anybody have any info or clarification on this and the potency of MPA? thank you ahead of time
 
After some research I have found some conflicting data basically indicating that thiopropamine ( unmethylated) is a releaser were as MPA is a re-uptake inhibitor with a preference for NE over DA. It does not make sense to me as methylation of a compound in my knowledge should not alter its pharmacological action that much.

anybody have any info or clarification on this and the potency of MPA? thank you ahead of time

MPA seems that to behave more like amphetamine (releasing agent) than coke,methylphenidate (re-uptake inhibitor).
One study "Neurochemical profiles of some novel psychoactive substances" mentioned only about it's re-uptake inhibitor properties.

Does anyone have any studies on the mechanism of action?
 
The very same question puzzles my mind right now (I know that the thread is five years old). According to Wikipedia it is a Noradrenaline and Dopamine reuptake inhibitor, but all releasing agents also act as reuptake inhibitors, so it seems likely to me that its action as a releasing agent has not been researched enough yet. Are there any new insights in this question?
 
Last edited:
it is a releaser just like methamphetamine.
 
It acts as a releaser for dopa and ne, mimics dopa ne and sert to some extent, thus acting as a reuptake inhibitor as its binding is stronger to the ports for reuptake yet isn't taken up into the neuron. This causes electrochemical excitability in the neuron as it signals strong activity at its ports and as a result creates a strong release on its other side, causing a chain reaction etc.
 
MPA seems that to behave more like amphetamine (releasing agent) than coke,methylphenidate (re-uptake inhibitor).
One study "Neurochemical profiles of some novel psychoactive substances" mentioned only about it's re-uptake inhibitor properties.

Does anyone have any studies on the mechanism of action?
Coke, like most local anaesthetics, lowers the excitability treshold of neurons by acting on the electrochemical side of things (desensibilizes the cation channels causing a cascade in "inorganic" exchanges), wich causes most of the potential for a high. It's the reuptake inhibition potential of coke or for example blaezocaine that then causes a "natural" high with the naturally present neurotransmitters unlike ampas where the neurotransmitters are mimicked. See explanation above. :)
 
it is indeed cited as a noradrenalin/dopamin reuptake inhibitor.


i thought bioisostere manipulation of the methamphetamine molecule might reveals just the same mechanism as an ne/dopamine releaser AND an reuptake inhibitor.
 
Last edited:
After some research I have found some conflicting data basically indicating that thiopropamine ( unmethylated) is a releaser were as MPA is a re-uptake inhibitor with a preference for NE over DA. It does not make sense to me as methylation of a compound in my knowledge should not alter its pharmacological action that much.

anybody have any info or clarification on this and the potency of MPA? thank you ahead of time
I believe the substrate area to the external binding of a sole reuptake inhibitor is the difference of one methylene unit.
 
Top